Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joon-Han Shin

Showing results (81-90 of 99) with videos related to

Pageof 10
Sort By:
Trials|February 14, 2018
Assessment of clinical effect and treatment quality of immediate-release carvedilol-IR versus SLOW release carvedilol-SR in Heart Failure patients (SLOW-HF): study protocol for a randomized controlled trialDong-Ju Choi, Chan Soon Park, Jin Joo Park, et al.
Trials|July 25, 2022
Correction: Assessment of clinical effect and treatment quality of immediate-release carvedilol-IR versus SLOW release carvedilol-SR in Heart Failure patients (SLOW-HF): study protocol for a randomized controlled trialDong-Ju Choi, Chan Soon Park, Jin Joo Park, et al.
Clinical Therapeutics|September 15, 2014
Point-of-care measurements of platelet inhibition after clopidogrel loading in patients with acute coronary syndrome: comparison of generic and branded clopidogrel bisulfateKyoung-Woo Seo, Seung-Jea Tahk, Hyoung-Mo Yang, et al.
Cardiovascular Drugs and Therapy|January 23, 2022
Clinical Characteristics and Outcome of Immediate-Release Versus SLOW-Release Carvedilol in Heart Failure Patient (SLOW-HF): a Prospective Randomized, Open-Label, Multicenter StudyChan Soon Park, Jin Joo Park, Hae-Young Lee, et al.
International Journal of Cardiology|March 21, 2015
The relationship between intravascular ultrasound-derived percent total atheroma volume and fractional flow reserve in the intermediate stenosis of proximal or middle left anterior descending coronary arteryXiong Jie Jin, Seung-Jea Tahk, Hyoung-Mo Yang, et al.
Clinical Therapeutics|August 25, 2021
Effects of Fixed-dose Combination of Low-intensity Rosuvastatin and Ezetimibe Versus Moderate-intensity Rosuvastatin Monotherapy on Lipid Profiles in Patients With Hypercholesterolemia: A Randomized, Double-blind, Multicenter, Phase III StudySeung-Ah Lee, Weon Kim, Taek Jong Hong, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|September 12, 2022
Efficacy and safety of low-dose antihypertensive combination of amlodipine, telmisartan, and chlorthalidone: A randomized, double-blind, parallel, phase II trialKi-Chul Sung, Jung Hoon Sung, Eun Joo Cho, et al.
Drug Design, Development and Therapy|August 31, 2016
Efficacy and safety of fixed-dose combination therapy with olmesartan medoxomil and rosuvastatin in Korean patients with mild to moderate hypertension and dyslipidemia: an 8-week, multicenter, randomized, double-blind, factorial-design study (OLSTA-D RCT: OLmesartan rosuvaSTAtin from Daewoong)Jin-Sun Park, Joon-Han Shin, Taek-Jong Hong, et al.
Drug Design, Development and Therapy|June 18, 2015
Efficacy of fimasartan/hydrochlorothiazide combination in hypertensive patients inadequately controlled by fimasartan monotherapyMoo-Yong Rhee, Sang Hong Baek, Weon Kim, et al.
Respiration; International Review of Thoracic Diseases|August 18, 2015
Independent risk factors for mortality in patients with chronic obstructive pulmonary disease who undergo comprehensive cardiac evaluationsYoung-Hwan Ahn, Keu Sung Lee, Joo Hun Park, et al.
Pageof 10

Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
Trials|February 14, 2018
Assessment of clinical effect and treatment quality of immediate-release carvedilol-IR versus SLOW release carvedilol-SR in Heart Failure patients (SLOW-HF): study protocol for a randomized controlled trialDong-Ju Choi, Chan Soon Park, Jin Joo Park, et al.
Trials|July 25, 2022
Correction: Assessment of clinical effect and treatment quality of immediate-release carvedilol-IR versus SLOW release carvedilol-SR in Heart Failure patients (SLOW-HF): study protocol for a randomized controlled trialDong-Ju Choi, Chan Soon Park, Jin Joo Park, et al.
Clinical Therapeutics|September 15, 2014
Point-of-care measurements of platelet inhibition after clopidogrel loading in patients with acute coronary syndrome: comparison of generic and branded clopidogrel bisulfateKyoung-Woo Seo, Seung-Jea Tahk, Hyoung-Mo Yang, et al.
Cardiovascular Drugs and Therapy|January 23, 2022
Clinical Characteristics and Outcome of Immediate-Release Versus SLOW-Release Carvedilol in Heart Failure Patient (SLOW-HF): a Prospective Randomized, Open-Label, Multicenter StudyChan Soon Park, Jin Joo Park, Hae-Young Lee, et al.
International Journal of Cardiology|March 21, 2015
The relationship between intravascular ultrasound-derived percent total atheroma volume and fractional flow reserve in the intermediate stenosis of proximal or middle left anterior descending coronary arteryXiong Jie Jin, Seung-Jea Tahk, Hyoung-Mo Yang, et al.
Clinical Therapeutics|August 25, 2021
Effects of Fixed-dose Combination of Low-intensity Rosuvastatin and Ezetimibe Versus Moderate-intensity Rosuvastatin Monotherapy on Lipid Profiles in Patients With Hypercholesterolemia: A Randomized, Double-blind, Multicenter, Phase III StudySeung-Ah Lee, Weon Kim, Taek Jong Hong, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|September 12, 2022
Efficacy and safety of low-dose antihypertensive combination of amlodipine, telmisartan, and chlorthalidone: A randomized, double-blind, parallel, phase II trialKi-Chul Sung, Jung Hoon Sung, Eun Joo Cho, et al.
Drug Design, Development and Therapy|August 31, 2016
Efficacy and safety of fixed-dose combination therapy with olmesartan medoxomil and rosuvastatin in Korean patients with mild to moderate hypertension and dyslipidemia: an 8-week, multicenter, randomized, double-blind, factorial-design study (OLSTA-D RCT: OLmesartan rosuvaSTAtin from Daewoong)Jin-Sun Park, Joon-Han Shin, Taek-Jong Hong, et al.
Drug Design, Development and Therapy|June 18, 2015
Efficacy of fimasartan/hydrochlorothiazide combination in hypertensive patients inadequately controlled by fimasartan monotherapyMoo-Yong Rhee, Sang Hong Baek, Weon Kim, et al.
Respiration; International Review of Thoracic Diseases|August 18, 2015
Independent risk factors for mortality in patients with chronic obstructive pulmonary disease who undergo comprehensive cardiac evaluationsYoung-Hwan Ahn, Keu Sung Lee, Joo Hun Park, et al.
Pageof 10